← Back to Search

Behavioral Intervention for Chronic Pain and Depression in Older Veterans (MOTIVATE_IIR Trial)

N/A
Recruiting
Led By Una E. Makris, MD MSc
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Pain intensity that is 4+/10 on the numerical pain rating scale
Aged 60 and older
Must not have
Self-reported dependence on wheelchair, bed-bound, or severe balance impairment or severe OA* (resulting in inability to participate in physical activity intervention)
Unwilling to be randomized to either study arm
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, mid (~5 weeks), end (~3 months) and 6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will test a new pain management program for older Veterans with both chronic pain and depression.

Who is the study for?
This trial is for older Veterans aged 60+ who speak English, have chronic musculoskeletal pain and depressive symptoms. They must be able to do home-based activities, score 10+ on the PHQ-9 depression scale, experience pain most days with an intensity of 4+/10 and interference level of 5+ on PEG-3. Exclusions include severe cognitive impairment, recent hospitalization that affects physical activity, suicidal intent or uncontrolled psychotic disorders.
What is being tested?
The MOTIVATE program is being tested in this study. It's a behavioral intervention aimed at improving outcomes for older veterans dealing with both musculoskeletal pain and depression by using non-pharmacologic methods tailored to be done at home.
What are the potential side effects?
Since MOTIVATE is a behavioral intervention involving non-drug approaches like exercise and mental health strategies rather than medication, it may not have typical 'side effects.' Participants might experience discomfort from new activities or emotional distress during therapy sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check β€œYes” for the criteria below
Select...
My pain level is at least 4 out of 10.
Select...
I am 60 years old or older.
Select...
I have scored 10 or higher on a depression screening test.
Select...
I have had muscle or joint pain almost daily for the past 3 months that affects my daily activities.
Select...
My pain often interferes with my daily activities.

Exclusion Criteria

You may be eligible for the trial if you check β€œNo” for criteria below:
Select...
I rely on a wheelchair, am bed-bound, or have severe balance issues or osteoarthritis that prevents me from being active.
Select...
I am not willing to be assigned randomly to a treatment group.
Select...
I can hear and see well enough to use a phone and read a pedometer.
Select...
I do not speak English.
Select...
I haven't been hospitalized for a condition that would stop me from exercising at home in the last 3 months.
Select...
I am 59 years old or younger.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, mid (~5 weeks), end (~3 months) and 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, mid (~5 weeks), end (~3 months) and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
: Pain interference
Secondary study objectives
Anxiety
Arthritis self-efficacy
Depressive symptoms, PHQ-9
+10 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Behavior Intervention Group (MOTIVATE)Experimental Treatment1 Intervention
For participants assigned to the intervention arm, trained health coaches will deliver the 8 session intervention via telephone. MOTIVATE users motivational interviewing techniques, values elicitation and physical activity based goal setting. All participants, regardless of what group they have been assigned to will undergo several outcome assessments (pre-screening, baseline, midpoint, final assessments) conducted by a blinded research assistant.
Group II: Waitlist Control GroupActive Control1 Intervention
The waitlist control group will continue with usual care management of musculoskeletal pain and depression. All participants, regardless of what group they have been assigned to will undergo several outcome assessments (pre-screening, baseline, midpoint, final assessments) conducted by a blinded research assistant. Subjects randomized to the waitlist control group will be offered the intervention once they have completed the end outcomes assessment.

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,663 Previous Clinical Trials
3,427,024 Total Patients Enrolled
78 Trials studying Depression
19,694 Patients Enrolled for Depression
Dallas VA Medical CenterFED
34 Previous Clinical Trials
4,572 Total Patients Enrolled
1 Trials studying Depression
50 Patients Enrolled for Depression
Michael E. DeBakey VA Medical CenterFED
66 Previous Clinical Trials
16,967 Total Patients Enrolled
3 Trials studying Depression
632 Patients Enrolled for Depression

Media Library

Behavioral Intervention Group (MOTIVATE) Clinical Trial Eligibility Overview. Trial Name: NCT05220202 β€” N/A
Depression Research Study Groups: Behavior Intervention Group (MOTIVATE), Waitlist Control Group
Depression Clinical Trial 2023: Behavioral Intervention Group (MOTIVATE) Highlights & Side Effects. Trial Name: NCT05220202 β€” N/A
Behavioral Intervention Group (MOTIVATE) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05220202 β€” N/A
~161 spots leftby Oct 2026